USA – Johnson & Johnson, the world’s largest health-care conglomerate, has announced plans to separate its consumer products business from its pharmaceutical and medical device operations, resulting in the formation of two publicly traded companies. The consumer arm – comprised of million- and billion-dollar brands and offering products such as mouthwash, shampoo, and skincare – will form a new publicly traded company in the next 18 to 24 months. The pharmaceutical and medical device division, which includes advanced technologies such as robotics and artificial intelligence, would keep the Johnson &…
Read MoreJohnson & Johnson to split into two publicly traded companies
